vs

Side-by-side financial comparison of Krystal Biotech, Inc. (KRYS) and RESOURCES CONNECTION, INC. (RGP). Click either name above to swap in a different company.

RESOURCES CONNECTION, INC. is the larger business by last-quarter revenue ($117.7M vs $107.1M, roughly 1.1× Krystal Biotech, Inc.). Krystal Biotech, Inc. runs the higher net margin — 48.0% vs -10.8%, a 58.7% gap on every dollar of revenue. On growth, Krystal Biotech, Inc. posted the faster year-over-year revenue change (17.5% vs -19.2%). Krystal Biotech, Inc. produced more free cash flow last quarter ($75.4M vs $15.6M). Over the past eight quarters, Krystal Biotech, Inc.'s revenue compounded faster (53.8% CAGR vs -11.8%).

Krystal Biotech, Inc. is a clinical-stage biotechnology company specializing in the research, development and commercialization of novel gene therapies for rare, serious dermatological diseases with high unmet medical needs. It primarily serves patients across North America and Europe, focusing on monogenic skin disorders that lack effective standard treatment options.

RGP, formerly known as Resources Global Professionals, is the operating arm of Resources Connection, Inc.. The company provides consulting services in the areas of finance & accounting, information management, governance, risk & compliance (GRC), human capital, legal & regulatory, corporate advisory & restructuring, strategic communications, and supply chain management. As of fiscal year ending May 28, 2016, the company employed 3,283 professionals in 68 offices in 20 countries around the wor...

KRYS vs RGP — Head-to-Head

Bigger by revenue
RGP
RGP
1.1× larger
RGP
$117.7M
$107.1M
KRYS
Growing faster (revenue YoY)
KRYS
KRYS
+36.7% gap
KRYS
17.5%
-19.2%
RGP
Higher net margin
KRYS
KRYS
58.7% more per $
KRYS
48.0%
-10.8%
RGP
More free cash flow
KRYS
KRYS
$59.8M more FCF
KRYS
$75.4M
$15.6M
RGP
Faster 2-yr revenue CAGR
KRYS
KRYS
Annualised
KRYS
53.8%
-11.8%
RGP

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
KRYS
KRYS
RGP
RGP
Revenue
$107.1M
$117.7M
Net Profit
$51.4M
$-12.7M
Gross Margin
37.1%
Operating Margin
41.5%
-10.3%
Net Margin
48.0%
-10.8%
Revenue YoY
17.5%
-19.2%
Net Profit YoY
13.0%
81.6%
EPS (diluted)
$1.69
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KRYS
KRYS
RGP
RGP
Q4 25
$107.1M
$117.7M
Q3 25
$97.8M
$120.2M
Q2 25
$96.0M
$139.3M
Q1 25
$88.2M
$129.4M
Q4 24
$91.1M
$145.6M
Q3 24
$83.8M
$136.9M
Q2 24
$70.3M
$148.2M
Q1 24
$45.3M
$151.3M
Net Profit
KRYS
KRYS
RGP
RGP
Q4 25
$51.4M
$-12.7M
Q3 25
$79.4M
$-2.4M
Q2 25
$38.3M
$-73.3M
Q1 25
$35.7M
$-44.1M
Q4 24
$45.5M
$-68.7M
Q3 24
$27.2M
$-5.7M
Q2 24
$15.6M
$10.5M
Q1 24
$932.0K
$2.5M
Gross Margin
KRYS
KRYS
RGP
RGP
Q4 25
37.1%
Q3 25
39.5%
Q2 25
40.2%
Q1 25
35.1%
Q4 24
38.5%
Q3 24
36.5%
Q2 24
40.2%
Q1 24
37.0%
Operating Margin
KRYS
KRYS
RGP
RGP
Q4 25
41.5%
-10.3%
Q3 25
42.3%
-1.7%
Q2 25
40.9%
-47.0%
Q1 25
41.0%
-38.4%
Q4 24
45.4%
-52.7%
Q3 24
26.8%
-3.5%
Q2 24
12.2%
7.6%
Q1 24
-14.8%
2.8%
Net Margin
KRYS
KRYS
RGP
RGP
Q4 25
48.0%
-10.8%
Q3 25
81.2%
-2.0%
Q2 25
39.9%
-52.6%
Q1 25
40.5%
-34.0%
Q4 24
49.9%
-47.2%
Q3 24
32.4%
-4.2%
Q2 24
22.2%
7.1%
Q1 24
2.1%
1.7%
EPS (diluted)
KRYS
KRYS
RGP
RGP
Q4 25
$1.69
$-0.38
Q3 25
$2.66
$-0.07
Q2 25
$1.29
$-2.21
Q1 25
$1.20
$-1.34
Q4 24
$1.53
$-2.08
Q3 24
$0.91
$-0.17
Q2 24
$0.53
$0.31
Q1 24
$0.03
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KRYS
KRYS
RGP
RGP
Cash + ST InvestmentsLiquidity on hand
$496.3M
$89.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.2B
$194.6M
Total Assets
$1.3B
$289.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KRYS
KRYS
RGP
RGP
Q4 25
$496.3M
$89.8M
Q3 25
$392.6M
$77.5M
Q2 25
$353.8M
$86.1M
Q1 25
$308.8M
$72.5M
Q4 24
$344.9M
$78.2M
Q3 24
$374.0M
$89.6M
Q2 24
$345.8M
$108.9M
Q1 24
$359.0M
$113.8M
Stockholders' Equity
KRYS
KRYS
RGP
RGP
Q4 25
$1.2B
$194.6M
Q3 25
$1.1B
$206.4M
Q2 25
$1.0B
$207.1M
Q1 25
$984.7M
$277.8M
Q4 24
$946.4M
$325.7M
Q3 24
$885.8M
$407.2M
Q2 24
$838.9M
$418.8M
Q1 24
$799.2M
$414.9M
Total Assets
KRYS
KRYS
RGP
RGP
Q4 25
$1.3B
$289.3M
Q3 25
$1.2B
$287.2M
Q2 25
$1.1B
$304.7M
Q1 25
$1.1B
$375.6M
Q4 24
$1.1B
$424.9M
Q3 24
$982.3M
$512.9M
Q2 24
$917.7M
$510.9M
Q1 24
$853.3M
$523.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KRYS
KRYS
RGP
RGP
Operating Cash FlowLast quarter
$77.5M
$15.9M
Free Cash FlowOCF − Capex
$75.4M
$15.6M
FCF MarginFCF / Revenue
70.4%
13.2%
Capex IntensityCapex / Revenue
2.0%
0.3%
Cash ConversionOCF / Net Profit
1.51×
TTM Free Cash FlowTrailing 4 quarters
$188.9M
$24.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KRYS
KRYS
RGP
RGP
Q4 25
$77.5M
$15.9M
Q3 25
$39.7M
$-7.8M
Q2 25
$52.7M
$16.8M
Q1 25
$31.0M
$659.0K
Q4 24
$52.8M
$1.8M
Q3 24
$58.9M
$-309.0K
Q2 24
$-4.2M
$3.2M
Q1 24
$15.9M
$20.5M
Free Cash Flow
KRYS
KRYS
RGP
RGP
Q4 25
$75.4M
$15.6M
Q3 25
$38.0M
$-8.0M
Q2 25
$50.8M
$16.5M
Q1 25
$24.8M
$238.0K
Q4 24
$52.0M
$61.0K
Q3 24
$57.8M
$-575.0K
Q2 24
$-5.3M
$3.0M
Q1 24
$14.6M
$20.4M
FCF Margin
KRYS
KRYS
RGP
RGP
Q4 25
70.4%
13.2%
Q3 25
38.8%
-6.6%
Q2 25
52.9%
11.8%
Q1 25
28.1%
0.2%
Q4 24
57.1%
0.0%
Q3 24
69.0%
-0.4%
Q2 24
-7.5%
2.1%
Q1 24
32.3%
13.5%
Capex Intensity
KRYS
KRYS
RGP
RGP
Q4 25
2.0%
0.3%
Q3 25
1.7%
0.1%
Q2 25
2.0%
0.2%
Q1 25
7.0%
0.3%
Q4 24
0.9%
1.2%
Q3 24
1.2%
0.2%
Q2 24
1.6%
0.1%
Q1 24
2.8%
0.1%
Cash Conversion
KRYS
KRYS
RGP
RGP
Q4 25
1.51×
Q3 25
0.50×
Q2 25
1.38×
Q1 25
0.87×
Q4 24
1.16×
Q3 24
2.17×
Q2 24
-0.27×
0.30×
Q1 24
17.05×
8.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KRYS
KRYS

Segment breakdown not available.

RGP
RGP

US$93.7M80%
Non Us$24.0M20%

Related Comparisons